ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search


CurrentAll Trials


Trial Details

A randomised, prospective study, assessing changes in cerebral function in treatment naive HIV-1 infected subjects commencing either boosted atazanavir with Truvada or boosted darunavir with maraviroc

Design and Objective

An open-label, prospective, randomised clinical trial to investigate differences in changes in neurocognitive function in HIV infected subjects commencing two different antiretroviral regimens for the first time.

Key inclusion criteria

HIV-1 infected males or females, aged 18 years or above, with no previous antiretroviral treatment since HIV diagnosis.

Study Disclaimer Statement